These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1308925)

  • 41. Clinical application of levofloxacin for severe infections.
    Tumminello B; Karaniewsky R; Gutierrez-Solana M
    Chemotherapy; 2006; 52(6):321. PubMed ID: 17047427
    [No Abstract]   [Full Text] [Related]  

  • 42. Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right back.
    Blondeau JM
    Future Microbiol; 2017 Jun; 12():549-553. PubMed ID: 28604102
    [No Abstract]   [Full Text] [Related]  

  • 43. The animal rule and emerging infections: the role of clinical pharmacology in determining an effective dose.
    Bergman KL
    Clin Pharmacol Ther; 2009 Sep; 86(3):328-31. PubMed ID: 19571806
    [No Abstract]   [Full Text] [Related]  

  • 44. Bovine colostrum--therapeutic synergism involving immunomodulation, nutritional supplementation and antibacterial action?
    Waaga-Gasser AM
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):191-2. PubMed ID: 17474537
    [No Abstract]   [Full Text] [Related]  

  • 45. Quinolones: which generation for which microbe?
    Lee MK; Kanatani MS
    West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165
    [No Abstract]   [Full Text] [Related]  

  • 46. Microbiologic aspects of fluoroquinolones.
    Neu HC
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tracking antibiotics up the food chain.
    Byrd DM; Cox LA; Wilson JD
    Science; 2001 Mar; 291(5513):2550. PubMed ID: 11286272
    [No Abstract]   [Full Text] [Related]  

  • 48. Antimicrobial resistance: a risk factor for infectious diseases.
    Roses Periago M
    Rev Panam Salud Publica; 2011 Dec; 30(6):507-8. PubMed ID: 22358393
    [No Abstract]   [Full Text] [Related]  

  • 49. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America.
    Marr JJ; Moffet HL; Kunin CM
    J Infect Dis; 1988 May; 157(5):869-76. PubMed ID: 3361154
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Septimus EJ; Kuper KM
    Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Counter resistance.
    Nat Microbiol; 2017 Apr; 2():17071. PubMed ID: 28440290
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapeutic failures with antimicrobial drug treatment.
    Roberts MC
    J Am Vet Med Assoc; 1984 Nov; 185(10):1150-4. PubMed ID: 6439710
    [No Abstract]   [Full Text] [Related]  

  • 53. Biomedicine and biotechnology: public health impact.
    Ganguly NK; Croft S; Singh L; Sinha S; Balganesh T
    Biomed Res Int; 2014; 2014():524785. PubMed ID: 24809051
    [No Abstract]   [Full Text] [Related]  

  • 54. Key aspects of antimicrobial stewardship.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S1. PubMed ID: 23677629
    [No Abstract]   [Full Text] [Related]  

  • 55. Key aspects of antimicrobial stewardship.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S1. PubMed ID: 23737332
    [No Abstract]   [Full Text] [Related]  

  • 56. Kunkel Lecture: Fundamental immunodeficiency and its correction.
    Nathan C
    J Exp Med; 2017 Aug; 214(8):2175-2191. PubMed ID: 28701368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?
    Thomson KS
    J Antimicrob Chemother; 2000 Jun; 45(6):719-23. PubMed ID: 10837422
    [No Abstract]   [Full Text] [Related]  

  • 58. Pets and antimicrobial resistance.
    Umber JK; Bender JB
    Vet Clin North Am Small Anim Pract; 2009 Mar; 39(2):279-92. PubMed ID: 19185194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial resistance to fluoroquinolones: mechanisms and patterns.
    Hooper DC
    Adv Exp Med Biol; 1995; 390():49-57. PubMed ID: 8718601
    [No Abstract]   [Full Text] [Related]  

  • 60. Host defense peptides for use as potential therapeutics.
    Zhang L; Falla TJ
    Curr Opin Investig Drugs; 2009 Feb; 10(2):164-71. PubMed ID: 19197794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.